West Pharmaceutical Servs (WST) Stock Price, Quote, News & History

West Pharmaceutical Services Inc (WST) Stock Price, Quote, News & History

WSTNYSE

Trade with Public

$245.86

1.510.62%

At close: Mar 5, 4:00 PM EST

$245.86

1.510.62%

Pre-Market: 4:02 AM EST

Key Statistics

Open

$245.86

Volume / Avg.

2.00 / 922.77K

Day Range

- - -

52 Wk Range

187.43 - 322.34

Market Cap

$17.69B

P/E Ratio

36.21

Dividend Yield

0.36%

Exchange

NYSE

RSI

Short Interest

4.09%

Days to Cover

1.66

Recent West Pharmaceutical Services Inc News

DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

Last week's biggest large-cap decliners included AeroVironment, DraftKings, AppLovin and Abbott, pressured by news, earnings and analyst actions.

Nabaparna Bhattacharya

AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines

AbbVie agrees to lower drug prices, invest $100 billion in the U.S., expand manufacturing, and secure tariff relief.

Vandana Singh

Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday?

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp rebound in crude prices and lifted energy shares.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

754.80M

Investing Cash Flow (TTM)

-285.90M

Financing Cash Flow (TTM)

-185.10M

Free Cash Flow (TTM)

468.90M

Capital Expenditure (TTM)

-285.90M

Net Change in Cash (TTM)

283.80M

Analyst Trends and Forecast

Sep 25

Oct 25

Dec 25

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$17.85B

PE Ratio (TTM)

36.21

PE Ratio (FWD)

32.79

PEG Ratio (TTM)

3.03

PS Ratio (TTM)

5.81

PB Ratio (TTM)

5.58

Earnings Yield % (TTM)

2.76%

Earnings Yield % (FWD)

3.05%

EV / EBITDA (TTM)

22.30

Price / EBITDA (TTM)

23.13

Price / Free Cash Flow (TTM)

38.12

Book Value / Share

$44.10

Company Debt

Total Debt

$202.80M

LT Debt

$202.80M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.10M

Total Cash

$791.30M

Debt to Equity

0.10

Issuance of Debt (TTM)

-$1.10M

Repayment of Debt (TTM)

-$1.10M

Key Statistics

Open

$245.86

Volume / Avg.

2.00 / 922.77K

Day Range

- - -

52 Wk Range

187.43 - 322.34

Market Cap

$17.69B

P/E Ratio

36.21

Dividend Yield

0.36%

Exchange

NYSE

RSI

Short Interest

4.09%

Days to Cover

1.66

About

Sector

Health Care

Industry

Life Sciences Tools & Services

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglas...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy West Pharmaceutical Servs (WST) stock?

You can purchase shares of West Pharmaceutical Servs (NYSE:WST) through any online brokerage.

View our list of the best stock brokerages

Who are West Pharmaceutical Servs (WST) competitors?

Other companies in West Pharmaceutical Servs’s space includes: Medpace Holdings Inc (NASDAQ:MEDP), Agilent Technologies Inc (NYSE:A), Icon PLC (NASDAQ:ICLR), 10x Genomics Inc (NASDAQ:TXG) and Waters Corp (NYSE:WAT).

What is the forecast, or price target, for West Pharmaceutical Servs (WST) stock?

West Pharmaceutical Servs has a consensus price target of $356.09.

What is the current price for West Pharmaceutical Servs (WST)?

The stock price for West Pharmaceutical Servs (NYSE: WST) is $245.86 last updated March 6, 2026 at 6:10 PM EST.

Does West Pharmaceutical Servs (WST) pay a dividend?

There are no upcoming dividends for West Pharmaceutical Servs.

When is West Pharmaceutical Servs (NYSE:WST) reporting earnings?

West Pharmaceutical Servs does not have any upcoming earnings scheduled.

Is West Pharmaceutical Servs (WST) going to split?

There is no upcoming split for West Pharmaceutical Servs.

What sector and industry does West Pharmaceutical Servs (WST) operate in?

West Pharmaceutical Servs is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

People Also Watch

Agilent Technologies Inc

AbCellera Biologics Inc

NASDAQ:ABCL

$3.46

Key Statistics

Open

$245.86

Volume / Avg.

2.00 / 922.77K

Day Range

- - -

52 Wk Range

187.43 - 322.34

Market Cap

$17.69B

P/E Ratio

36.21

Dividend Yield

0.36%

Exchange

NYSE

RSI

Short Interest

4.09%

Days to Cover

1.66

Recent West Pharmaceutical Services Inc News

DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

Last week's biggest large-cap decliners included AeroVironment, DraftKings, AppLovin and Abbott, pressured by news, earnings and analyst actions.

Nabaparna Bhattacharya

AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines

AbbVie agrees to lower drug prices, invest $100 billion in the U.S., expand manufacturing, and secure tariff relief.

Vandana Singh

Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday?

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp rebound in crude prices and lifted energy shares.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

754.80M

Investing Cash Flow (TTM)

-285.90M

Financing Cash Flow (TTM)

-185.10M

Free Cash Flow (TTM)

468.90M

Capital Expenditure (TTM)

-285.90M

Net Change in Cash (TTM)

283.80M

Analyst Trends and Forecast

Sep 25

Oct 25

Dec 25

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$17.85B

PE Ratio (TTM)

36.21

PE Ratio (FWD)

32.79

PEG Ratio (TTM)

3.03

PS Ratio (TTM)

5.81

PB Ratio (TTM)

5.58

Earnings Yield % (TTM)

2.76%

Earnings Yield % (FWD)

3.05%

EV / EBITDA (TTM)

22.30

Price / EBITDA (TTM)

23.13

Price / Free Cash Flow (TTM)

38.12

Book Value / Share

$44.10

Company Debt

Total Debt

$202.80M

LT Debt

$202.80M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.10M

Total Cash

$791.30M

Debt to Equity

0.10

Issuance of Debt (TTM)

-$1.10M

Repayment of Debt (TTM)

-$1.10M

Key Statistics

Open

$245.86

Volume / Avg.

2.00 / 922.77K

Day Range

- - -

52 Wk Range

187.43 - 322.34

Market Cap

$17.69B

P/E Ratio

36.21

Dividend Yield

0.36%

Exchange

NYSE

RSI

Short Interest

4.09%

Days to Cover

1.66

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry